Effectiveness and Safety of Mirikizumab after Switching from Ustekinumab in Patients with Moderate to Severe Crohn's Disease: Results from a Long-Term Extension Study
JOURNAL OF CROHNS & COLITIS（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined